IBDEI02N ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3045,1,4,0)
 ;;=4^V75.7
 ;;^UTILITY(U,$J,358.3,3045,2)
 ;;=^295648
 ;;^UTILITY(U,$J,358.3,3046,0)
 ;;=V75.8^^35^237^43
 ;;^UTILITY(U,$J,358.3,3046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3046,1,3,0)
 ;;=3^SCREEN-PARASITIC DIS NEC
 ;;^UTILITY(U,$J,358.3,3046,1,4,0)
 ;;=4^V75.8
 ;;^UTILITY(U,$J,358.3,3046,2)
 ;;=^295649
 ;;^UTILITY(U,$J,358.3,3047,0)
 ;;=V76.0^^35^237^24
 ;;^UTILITY(U,$J,358.3,3047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3047,1,3,0)
 ;;=3^SCREEN MAL NEOP-RESP ORG
 ;;^UTILITY(U,$J,358.3,3047,1,4,0)
 ;;=4^V76.0
 ;;^UTILITY(U,$J,358.3,3047,2)
 ;;=^295651
 ;;^UTILITY(U,$J,358.3,3048,0)
 ;;=V76.10^^35^237^26
 ;;^UTILITY(U,$J,358.3,3048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3048,1,3,0)
 ;;=3^SCREEN MAL NEOPL, BREAST,UNSP
 ;;^UTILITY(U,$J,358.3,3048,1,4,0)
 ;;=4^V76.10
 ;;^UTILITY(U,$J,358.3,3048,2)
 ;;=^317968
 ;;^UTILITY(U,$J,358.3,3049,0)
 ;;=V76.11^^35^237^27
 ;;^UTILITY(U,$J,358.3,3049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3049,1,3,0)
 ;;=3^SCREEN MAMMO HIGH-RISK PT
 ;;^UTILITY(U,$J,358.3,3049,1,4,0)
 ;;=4^V76.11
 ;;^UTILITY(U,$J,358.3,3049,2)
 ;;=^317969
 ;;^UTILITY(U,$J,358.3,3050,0)
 ;;=V76.12^^35^237^8
 ;;^UTILITY(U,$J,358.3,3050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3050,1,3,0)
 ;;=3^OTHER SCREEN MAMMO FOR MAL NEO
 ;;^UTILITY(U,$J,358.3,3050,1,4,0)
 ;;=4^V76.12
 ;;^UTILITY(U,$J,358.3,3050,2)
 ;;=^317970
 ;;^UTILITY(U,$J,358.3,3051,0)
 ;;=V76.19^^35^237^7
 ;;^UTILITY(U,$J,358.3,3051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3051,1,3,0)
 ;;=3^OTHER SCREEN BREAST EXAM
 ;;^UTILITY(U,$J,358.3,3051,1,4,0)
 ;;=4^V76.19
 ;;^UTILITY(U,$J,358.3,3051,2)
 ;;=^295652
 ;;^UTILITY(U,$J,358.3,3052,0)
 ;;=V76.2^^35^237^21
 ;;^UTILITY(U,$J,358.3,3052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3052,1,3,0)
 ;;=3^SCREEN MAL NEOP-CERVIX
 ;;^UTILITY(U,$J,358.3,3052,1,4,0)
 ;;=4^V76.2
 ;;^UTILITY(U,$J,358.3,3052,2)
 ;;=^295653
 ;;^UTILITY(U,$J,358.3,3053,0)
 ;;=V76.3^^35^237^20
 ;;^UTILITY(U,$J,358.3,3053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3053,1,3,0)
 ;;=3^SCREEN MAL NEOP-BLADDER
 ;;^UTILITY(U,$J,358.3,3053,1,4,0)
 ;;=4^V76.3
 ;;^UTILITY(U,$J,358.3,3053,2)
 ;;=^295654
 ;;^UTILITY(U,$J,358.3,3054,0)
 ;;=V76.41^^35^237^23
 ;;^UTILITY(U,$J,358.3,3054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3054,1,3,0)
 ;;=3^SCREEN MAL NEOP-RECTUM
 ;;^UTILITY(U,$J,358.3,3054,1,4,0)
 ;;=4^V76.41
 ;;^UTILITY(U,$J,358.3,3054,2)
 ;;=^295655
 ;;^UTILITY(U,$J,358.3,3055,0)
 ;;=V76.42^^35^237^22
 ;;^UTILITY(U,$J,358.3,3055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3055,1,3,0)
 ;;=3^SCREEN MAL NEOP-ORAL CAV
 ;;^UTILITY(U,$J,358.3,3055,1,4,0)
 ;;=4^V76.42
 ;;^UTILITY(U,$J,358.3,3055,2)
 ;;=^295656
 ;;^UTILITY(U,$J,358.3,3056,0)
 ;;=V76.43^^35^237^25
 ;;^UTILITY(U,$J,358.3,3056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3056,1,3,0)
 ;;=3^SCREEN MAL NEOP-SKIN
 ;;^UTILITY(U,$J,358.3,3056,1,4,0)
 ;;=4^V76.43
 ;;^UTILITY(U,$J,358.3,3056,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,3057,0)
 ;;=V76.44^^35^237^73
 ;;^UTILITY(U,$J,358.3,3057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3057,1,3,0)
 ;;=3^SP SCR-MALIG NEOP PROSTATE
 ;;^UTILITY(U,$J,358.3,3057,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,3057,2)
 ;;=^321548
 ;;^UTILITY(U,$J,358.3,3058,0)
 ;;=V76.45^^35^237^74
 ;;^UTILITY(U,$J,358.3,3058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3058,1,3,0)
 ;;=3^SP SCR-MALIG NEOP TESTIS
 ;;^UTILITY(U,$J,358.3,3058,1,4,0)
 ;;=4^V76.45
 ;;^UTILITY(U,$J,358.3,3058,2)
 ;;=^321549
 ;;^UTILITY(U,$J,358.3,3059,0)
 ;;=V76.46^^35^237^82
 ;;^UTILITY(U,$J,358.3,3059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3059,1,3,0)
 ;;=3^SPEC SCRN MALIG NEOPLASM,OVARY
 ;;^UTILITY(U,$J,358.3,3059,1,4,0)
 ;;=4^V76.46
 ;;^UTILITY(U,$J,358.3,3059,2)
 ;;=^322084
 ;;^UTILITY(U,$J,358.3,3060,0)
 ;;=V76.47^^35^237^81
 ;;^UTILITY(U,$J,358.3,3060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3060,1,3,0)
 ;;=3^SPEC SCRN MALIG NEOPLAS,VAGINA
 ;;^UTILITY(U,$J,358.3,3060,1,4,0)
 ;;=4^V76.47
 ;;^UTILITY(U,$J,358.3,3060,2)
 ;;=^322085
 ;;^UTILITY(U,$J,358.3,3061,0)
 ;;=V76.50^^35^237^77
 ;;^UTILITY(U,$J,358.3,3061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3061,1,3,0)
 ;;=3^SPC SCRN MALIG NEO,UNS INTESTI
 ;;^UTILITY(U,$J,358.3,3061,1,4,0)
 ;;=4^V76.50
 ;;^UTILITY(U,$J,358.3,3061,2)
 ;;=^322088
 ;;^UTILITY(U,$J,358.3,3062,0)
 ;;=V76.51^^35^237^78
 ;;^UTILITY(U,$J,358.3,3062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3062,1,3,0)
 ;;=3^SPC SCRN MALIG NEOPLASM,COLON
 ;;^UTILITY(U,$J,358.3,3062,1,4,0)
 ;;=4^V76.51
 ;;^UTILITY(U,$J,358.3,3062,2)
 ;;=^322089
 ;;^UTILITY(U,$J,358.3,3063,0)
 ;;=V76.81^^35^237^76
 ;;^UTILITY(U,$J,358.3,3063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3063,1,3,0)
 ;;=3^SPC SCRN MALIG NEO,NERV SYS
 ;;^UTILITY(U,$J,358.3,3063,1,4,0)
 ;;=4^V76.81
 ;;^UTILITY(U,$J,358.3,3063,2)
 ;;=^322091
 ;;^UTILITY(U,$J,358.3,3064,0)
 ;;=V77.0^^35^237^51
 ;;^UTILITY(U,$J,358.3,3064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3064,1,3,0)
 ;;=3^SCREEN-THYROID DISORDER
 ;;^UTILITY(U,$J,358.3,3064,1,4,0)
 ;;=4^V77.0
 ;;^UTILITY(U,$J,358.3,3064,2)
 ;;=^295661
 ;;^UTILITY(U,$J,358.3,3065,0)
 ;;=V77.1^^35^237^36
 ;;^UTILITY(U,$J,358.3,3065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3065,1,3,0)
 ;;=3^SCREEN-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,3065,1,4,0)
 ;;=4^V77.1
 ;;^UTILITY(U,$J,358.3,3065,2)
 ;;=^295662
 ;;^UTILITY(U,$J,358.3,3066,0)
 ;;=V77.2^^35^237^16
 ;;^UTILITY(U,$J,358.3,3066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3066,1,3,0)
 ;;=3^SCREEN FOR MALNUTRITION
 ;;^UTILITY(U,$J,358.3,3066,1,4,0)
 ;;=4^V77.2
 ;;^UTILITY(U,$J,358.3,3066,2)
 ;;=^295663
 ;;^UTILITY(U,$J,358.3,3067,0)
 ;;=V77.3^^35^237^44
 ;;^UTILITY(U,$J,358.3,3067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3067,1,3,0)
 ;;=3^SCREEN-PHENYLKETONURIA
 ;;^UTILITY(U,$J,358.3,3067,1,4,0)
 ;;=4^V77.3
 ;;^UTILITY(U,$J,358.3,3067,2)
 ;;=^295664
 ;;^UTILITY(U,$J,358.3,3068,0)
 ;;=V77.4^^35^237^11
 ;;^UTILITY(U,$J,358.3,3068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3068,1,3,0)
 ;;=3^SCREEN FOR GALACTOSEMIA
 ;;^UTILITY(U,$J,358.3,3068,1,4,0)
 ;;=4^V77.4
 ;;^UTILITY(U,$J,358.3,3068,2)
 ;;=^295665
 ;;^UTILITY(U,$J,358.3,3069,0)
 ;;=V77.5^^35^237^60
 ;;^UTILITY(U,$J,358.3,3069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3069,1,3,0)
 ;;=3^SCREENING FOR GOUT
 ;;^UTILITY(U,$J,358.3,3069,1,4,0)
 ;;=4^V77.5
 ;;^UTILITY(U,$J,358.3,3069,2)
 ;;=^295666
 ;;^UTILITY(U,$J,358.3,3070,0)
 ;;=V77.6^^35^237^34
 ;;^UTILITY(U,$J,358.3,3070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3070,1,3,0)
 ;;=3^SCREEN-CYSTIC FIBROSIS
 ;;^UTILITY(U,$J,358.3,3070,1,4,0)
 ;;=4^V77.6
 ;;^UTILITY(U,$J,358.3,3070,2)
 ;;=^295667
 ;;^UTILITY(U,$J,358.3,3071,0)
 ;;=V77.7^^35^237^38
 ;;^UTILITY(U,$J,358.3,3071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3071,1,3,0)
 ;;=3^SCREEN-INBORN ERR METAB
 ;;^UTILITY(U,$J,358.3,3071,1,4,0)
 ;;=4^V77.7
 ;;^UTILITY(U,$J,358.3,3071,2)
 ;;=^295668
 ;;^UTILITY(U,$J,358.3,3072,0)
 ;;=V77.8^^35^237^63
 ;;^UTILITY(U,$J,358.3,3072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3072,1,3,0)
 ;;=3^SCREENING FOR OBESITY
 ;;^UTILITY(U,$J,358.3,3072,1,4,0)
 ;;=4^V77.8
 ;;^UTILITY(U,$J,358.3,3072,2)
 ;;=^295669
 ;;^UTILITY(U,$J,358.3,3073,0)
 ;;=V77.91^^35^237^65
 ;;^UTILITY(U,$J,358.3,3073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3073,1,3,0)
 ;;=3^SCREENING LIPOID DISORDERS
 ;;^UTILITY(U,$J,358.3,3073,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,3073,2)
 ;;=^322093
 ;;^UTILITY(U,$J,358.3,3074,0)
 ;;=V78.0^^35^237^39
 ;;^UTILITY(U,$J,358.3,3074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3074,1,3,0)
 ;;=3^SCREEN-IRON DEFIC ANEMIA
 ;;^UTILITY(U,$J,358.3,3074,1,4,0)
 ;;=4^V78.0
 ;;^UTILITY(U,$J,358.3,3074,2)
 ;;=^295671
 ;;^UTILITY(U,$J,358.3,3075,0)
 ;;=V78.1^^35^237^35
 ;;^UTILITY(U,$J,358.3,3075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3075,1,3,0)
 ;;=3^SCREEN-DEFIC ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,3075,1,4,0)
 ;;=4^V78.1
 ;;^UTILITY(U,$J,358.3,3075,2)
 ;;=^295672
 ;;^UTILITY(U,$J,358.3,3076,0)
 ;;=V78.2^^35^237^50
 ;;^UTILITY(U,$J,358.3,3076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3076,1,3,0)
 ;;=3^SCREEN-SICKLE CELL DIS
 ;;^UTILITY(U,$J,358.3,3076,1,4,0)
 ;;=4^V78.2
 ;;^UTILITY(U,$J,358.3,3076,2)
 ;;=^295673
 ;;^UTILITY(U,$J,358.3,3077,0)
 ;;=V78.3^^35^237^69
 ;;^UTILITY(U,$J,358.3,3077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3077,1,3,0)
 ;;=3^SCRN-HEMOGLOBINOPATH NEC
 ;;^UTILITY(U,$J,358.3,3077,1,4,0)
 ;;=4^V78.3
 ;;^UTILITY(U,$J,358.3,3077,2)
 ;;=^295674
 ;;^UTILITY(U,$J,358.3,3078,0)
 ;;=V79.0^^35^237^56
 ;;^UTILITY(U,$J,358.3,3078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3078,1,3,0)
 ;;=3^SCREENING FOR DEPRESSION
 ;;^UTILITY(U,$J,358.3,3078,1,4,0)
 ;;=4^V79.0
 ;;^UTILITY(U,$J,358.3,3078,2)
 ;;=^295677
 ;;^UTILITY(U,$J,358.3,3079,0)
 ;;=V79.1^^35^237^54
 ;;^UTILITY(U,$J,358.3,3079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3079,1,3,0)
 ;;=3^SCREENING FOR ALCOHOLISM
 ;;^UTILITY(U,$J,358.3,3079,1,4,0)
 ;;=4^V79.1
 ;;^UTILITY(U,$J,358.3,3079,2)
 ;;=^295678
 ;;^UTILITY(U,$J,358.3,3080,0)
 ;;=V79.8^^35^237^40
 ;;^UTILITY(U,$J,358.3,3080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3080,1,3,0)
 ;;=3^SCREEN-MENTAL DIS NEC
 ;;^UTILITY(U,$J,358.3,3080,1,4,0)
 ;;=4^V79.8
 ;;^UTILITY(U,$J,358.3,3080,2)
 ;;=^295681
 ;;^UTILITY(U,$J,358.3,3081,0)
 ;;=V80.01^^35^237^52
 ;;^UTILITY(U,$J,358.3,3081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3081,1,3,0)
 ;;=3^SCREEN-TRAUMTC BRAIN INJ
 ;;^UTILITY(U,$J,358.3,3081,1,4,0)
 ;;=4^V80.01
 ;;^UTILITY(U,$J,358.3,3081,2)
 ;;=^338517
 ;;^UTILITY(U,$J,358.3,3082,0)
 ;;=V80.09^^35^237^42
 ;;^UTILITY(U,$J,358.3,3082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3082,1,3,0)
 ;;=3^SCREEN-NEURO CONDITION
 ;;^UTILITY(U,$J,358.3,3082,1,4,0)
 ;;=4^V80.09
 ;;^UTILITY(U,$J,358.3,3082,2)
 ;;=^338518
 ;;^UTILITY(U,$J,358.3,3083,0)
 ;;=V80.1^^35^237^59
 ;;^UTILITY(U,$J,358.3,3083,1,0)
 ;;=^358.31IA^4^2
